Epilepsy, Temporal Lobe
31
9
9
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.2%
1 terminated out of 31 trials
92.3%
+5.8% vs benchmark
6%
2 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (31)
A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy
Surgery as a Treatment for Medically Intractable Epilepsy
Investigating Epilepsy: Screening and Evaluation
Localizing Epileptic Networks Using MRI and iEEG
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Stimulation of the Thalamus for Arousal Restoral in Temporal Lobe Epilepsy
Evaluation of the NaviFUS System in Drug Resistant Epilepsy
Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients
Treating Deep Seizure Foci With Noninvasive Surface Brain Stimulation
Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy
Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus
Innovative MRI to Localize the Epileptic Zone
Low-intensity Focused Ultrasound Pulsation (LIFUP) for Treatment of Temporal Lobe Epilepsy
Epilepsy Surgery and Cognitive Outcome
A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score
SEEG Guided RF-TC v.s. ATL for mTLE With HS
Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback
EASINESS-TRIAL - Enhancing Safety in Epilepsy Surgery
Structural Cartography of the Insula in Temporal Epilepsy Patients
A Deep Learning Framework for Pediatric TLE Detection Using 18F-FDG-PET Imaging